You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperlipidemia

Showing 1 - 25 of 1,649
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Hyperlipidemia Trial

Not yet recruiting
  • Familial Hyperlipidemia
    • (no location specified)
    Apr 12, 2023

    Hyperlipidemia, Hyperglycemia, Type 2 Diabetes Trial in Taipei (Adlay with white rice, white rice)

    Recruiting
    • Hyperlipidemia
    • +2 more
    • Adlay with white rice
    • white rice
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 17, 2023

    Combined Hyperlipidemia Trial in Moscow, Nizhny Novgorod, Yaroslavl ("Phospholipovit", Placebo)

    Completed
    • Combined Hyperlipidemia
    • Moscow, Russian Federation
    • +2 more
    Feb 14, 2023

    Cardiometabolic Disease, Hyperlipidemia Trial in Beijing (Telehealth integrated care, Conventional health care)

    Recruiting
    • Cardiometabolic Disease
    • Hyperlipidemia
    • Telehealth integrated care
    • Conventional health care
    • Beijing, Beijing, China
      Peking University Third Hospital
    Sep 1, 2023

    Program With Lipid Screening asMeans to Identify Familial

    Enrolling by invitation
    • Familial Hyperlipidemia
      • Loveland, Colorado
        Medical Center of the Rockies
      Mar 2, 2023

      Hyperlipidemia Trial in Guangzhou (SHR-1209, Placebo)

      Completed
      • Hyperlipidemia
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital ,The Second Affiliated Hospital of
      Nov 29, 2022

      Hyperlipidemias, Obesity, Body Fat Disorder Trial (Xian-Hua-Cha)

      Not yet recruiting
      • Hyperlipidemias
      • +2 more
      • (no location specified)
      Nov 20, 2022

      Epilepsy, Hypertension, Hyperlipidemia (E.G., Hypercholesterolemia) Trial (Neurologist Initiated Treatment, Placebo)

      Not yet recruiting
      • Epilepsy
      • +2 more
      • Neurologist Initiated Treatment
      • Placebo
      • (no location specified)
      Jan 27, 2023

      Non-surgical Periodontal Therapy on Severe Periodontitis and

      Recruiting
      • Periodontitis Chronic Generalized Severe
      • +5 more
      • non-surgical periodontal therapy
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Sep 17, 2022

      Hypercholesterolemia, Hyperlipidemia Trial in Beijing (SHR-1209 ;)

      Active, not recruiting
      • Hypercholesterolemia
      • Hyperlipidemia
      • SHR-1209 ;placebo
      • Beijing, Beijing, China
        Beijing Anzhen Hospital, Capital Medical University
      May 23, 2022

      Hyperlipidemia Trial in Beijing (AK102, Placebo)

      Recruiting
      • Hyperlipidemia
      • AK102
      • Placebo
      • Beijing, China
        Peking University First Hospital
      Feb 15, 2022

      Hyperlipidemia Trial in Nanchang (AK102, Placebo)

      Recruiting
      • Hyperlipidemia
      • AK102
      • Placebo
      • Nanchang, Jiangxi, China
        The Third Hospital of Nanchang
      Feb 15, 2022

      Hyperlipidemia Trial in Hangzhou, Shanghai (AK102, Placebo)

      Recruiting
      • Hyperlipidemia
      • AK102
      • Placebo
      • Hangzhou, Zhejiang, China
      • +1 more
      Feb 18, 2022

      Hypertension and Hyperlipidemia Trial in Philadelphia (HTN and Medication Adherence)

      Recruiting
      • Hypertension and Hyperlipidemia
      • HTN and Medication Adherence
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Sep 27, 2022

      Type 2 Diabetes Trial in Seoul (Irbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin)

      Completed
      • Type 2 Diabetes Mellitus
      • Irbesartan/atorvastatin fixed dose combination
      • +2 more
      • Seoul, Korea, Republic of
        Korea
      Apr 5, 2022

      Hyperlipidemia Trial in Beijing (JS401, Placebo)

      Recruiting
      • Hyperlipidemia
      • Beijing, Beijing, China
        Peking University Third Hospital
      Sep 15, 2023

      Hypertension, Hyperlipidemias Trial ((D) DWC202206, (D) DWC202207, (P) DWC202206)

      Not yet recruiting
      • Hypertension
      • Hyperlipidemias
      • (D) DWC202206
      • +3 more
      • (no location specified)
      Dec 8, 2022

      Lipoprotein Metabolism in Normal Volunteers and High Levels of

      Completed
      • Hypolipoproteinemia
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Diabetes, Lipodystrophy, Hyperlipidemia Trial run by the NIDDK (Metreleptin)

        Active, not recruiting
        • Diabetes
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Hypercholesterolemia, Hyperlipidemias, Dietary Supplements Trial in Madrid (Experimental product, Placebo product)

        Completed
        • Hypercholesterolemia
        • +3 more
        • Experimental product
        • Placebo product
        • Madrid, Spain
          Institute for Health Research IdiPAZ
        Jan 12, 2022

        Lipodystrophy, Diabetes, Hyperlipidemia Trial run by the NIDDK (Metreleptin)

        Recruiting
        • Lipodystrophy
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        NASH - Nonalcoholic Steatohepatitis Trial in Rennes (ALG-055009, Placebo)

        Recruiting
        • NASH - Nonalcoholic Steatohepatitis
        • Rennes, France
          Biotrial
        Dec 21, 2021

        Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40

        Completed
        • Hypertension
        • Hyperlipidemias
        • Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
        • +2 more
        • Seoul, Korea, Republic of
          Seoul national university bundang hospital
        Dec 20, 2021

        Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)

        Completed
        • Hyperlipidemia
        • Cholesfytol NG®) supplement
        • Leuven, Belgium
          Cliniques universitaires St-Luc and Institut de Recherche Expéri
        Aug 18, 2023

        Hyperlipidemias Trial in Montreal (CP105F, Placebo)

        Completed
        • Hyperlipidemias
        • Montreal, Quebec, Canada
          Montreal Heart Institute
        Jan 14, 2022